Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of SpeeDx's Ciprofloxacin gyrA Assay for Clinical Care of STD Clinic Patients With Neisseria Gonorrhea

NCT05286931 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT05286931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05286931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of SpeeDx's Ciprofloxacin gyrA Assay for Clinical Care of STD Clinic Patients With Neisseria Gonorrhea
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Recruiting
Start date
March 3, 2022
Completion date
December 31, 2026
Enrollment
1,800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neisseria gonorrhoeae infection